Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

Schleicher S, Moore A, Rafal E, Gagne-Henley A, Johnson SM, Dhawan S, Chavda R, York JP, Sforzolini B, Holcomb K, Ablon G, Del Rosso J, Dreno B

Open source

DOI
10.1007/s13555-023-01042-7
Published
2023 Dec
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-023-01042-7,
  title = {Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.},
  author = {Schleicher S and Moore A and Rafal E and Gagne-Henley A and Johnson SM and Dhawan S and Chavda R and York JP and Sforzolini B and Holcomb K and Ablon G and Del Rosso J and Dreno B},
  year = {2023},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-023-01042-7},
  url = {https://doi.org/10.1007/s13555-023-01042-7}
}

RIS

TY  - JOUR
TI  - Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
AU  - Schleicher S
AU  - Moore A
AU  - Rafal E
AU  - Gagne-Henley A
AU  - Johnson SM
AU  - Dhawan S
AU  - Chavda R
AU  - York JP
AU  - Sforzolini B
AU  - Holcomb K
AU  - Ablon G
AU  - Del Rosso J
AU  - Dreno B
PY  - 2023
JO  - Dermatology and therapy
DO  - 10.1007/s13555-023-01042-7
UR  - https://doi.org/10.1007/s13555-023-01042-7
ER  - 

APA

S, S., A, M., E, R., A, G., SM, J., S, D., R, C., JP, Y., B, S., K, H., G, A., J, D. R., & B, D. (2023). Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.. Dermatology and therapy. https://doi.org/10.1007/s13555-023-01042-7

Source records